Related Experiment Video
Updated: Dec 7, 2025
Author Spotlight: Investigating Wound Healing in Mice Models of Oronasal Fistulas
Published on: September 8, 2023
The Effect of Surgical Timing on 30-Day Outcomes in Cleft Palate Repair
Connor J Peck1, Arvind U Gowda1, Blake N Shultz1
1From the Department of Surgery, Section of Plastic Surgery, Yale School of Medicine.
Insights
Cleft palate repair before 6 months is linked to increased complications, readmissions, and reoperations. Optimal timing balances surgical risk with long-term speech outcomes, guiding surgical decisions.
Area of Science:
- Pediatric Surgery
- Craniofacial Surgery
- Surgical Outcomes Research
Background:
- The optimal timing for cleft palate repair remains debated, with limited data on surgical risk associated with operative timing.
- This study investigates the impact of surgical timing on perioperative and early postoperative outcomes in cleft palate patients.
Purpose of the Study:
- To analyze the effect of surgical timing on perioperative and 30-day postoperative outcomes in cleft palate repair.
- To provide evidence-based guidance for surgeons and parents in surgical decision-making regarding palatoplasty timing.
Main Methods:
- Retrospective analysis of 3088 primary cleft palate repairs from the National Surgical Quality Improvement Program database (2012-2015).
- Data collected included postoperative complications, readmission rates, reoperation rates, operating room time, and length of stay.
- Bivariate analyses compared outcomes across different age groups, focusing on periods from 0-5 months and 6-59 months.
Main Results:
- Children undergoing cleft palate repair before 6 months had significantly higher complication rates (7.1% vs. 3.2%), readmission rates (3.6% vs. 1.4%), and reoperation rates (2.4% vs. 0.5%) compared to older age groups.
- No significant differences in short-term outcomes were observed for other age groups younger than 5 years.
- Hospital length of stay did not differ significantly among any age groups.
Conclusions:
- Early cleft palate repair before 6 months presents a relative contraindication due to increased perioperative risks.
- Long-term speech optimization should remain the primary consideration for operative planning, as no significant differences were found between other age groups.
- These findings refine the rationale for palatoplasty timing, aiding clinical decision-making for surgeons and families.
Background:
The optimal age for cleft palate repair continues to be debated, with little discussion of surgical risk related to operative timing. This study of 3088 cleft palate patients analyzed the impact of surgical timing on perioperative and 30-day postoperative outcomes.
Methods:
Primary cleft palate repairs were identified in the National Surgical Quality Improvement Program database from 2012 to 2015. Data were combed for total postoperative complications, rates of readmission and reoperation, operating room time, and length of stay. Bivariate analyses were performed comparing 3-month periods from months 6 to 18, and months 0 to 5, 18 to 23, 24 to 29, and 30 to 59.
Results:
Despite a higher proportion of isolated soft palate closure, children operated on before 6 months had a higher complication rate than children at other ages (7.1 percent versus 3.2 percent; OR, 2.4; p = 0.04), and higher rates of both readmission (3.6 percent versus 1.4 percent; OR, 3.6; p = 0.02) and reoperation (2.4 percent versus 0.5 percent; OR, 4.7; p = 0.04). There were no differences in short-term outcomes for any other age group younger than 5 years, and no differences in hospital length of stay among any age groups.
Conclusions:
The authors' findings suggest a relative contraindication to operation before 6 months. As there were no differences between any other age groups, long-term speech optimization should continue to be the primary consideration for operative planning. These findings improve the current rationale for palatoplasty timing, and can aid surgeons and parents in the surgical decision-making process.
Clinical Question/Level Of Evidence:
Therapeutic, III.
